Zinger Key Points
- Analyst downgrades Beyond, citing delayed EBITDA milestone until 2027, causing stock volatility risk.
- The analyst acknowledges that margins have performed better than expected, primarily due to improved sales and marketing efforts.
- Our government trade tracker caught Pelosi’s 169% AI winner. Discover how to track all 535 Congress member stock trades today.
Needham analyst Bernie McTernan downgraded Beyond, Inc. BYON from Buy to Hold and removed the prior price forecast of $9.
The analyst suggests that the risk-reward for Beyond shares has become less favorable due to significant reductions in revenue estimates over the past six months.
While management has successfully cut costs and improved margins, the analyst adds that there was more unprofitable revenue than originally anticipated.
According to the analyst, the company is still expected to reach adjusted EBITDA-positive, but this milestone is now pushed out to 2027, which could lead to increased volatility in the stock as the company navigates its turnaround.
Also Read: Trump Considering Tariff Relief For Mexico, Canada, Commerce Secretary Lutnick Says
The analyst projects the company to report FY25 EBITDA of $(59.6) million, compared with the previous estimate of $(68.7) million.
The analyst acknowledges that margins have performed better than expected, primarily due to improved sales and marketing efforts. Meanwhile, there are concerns about the company’s ability to simultaneously accelerate revenue growth while maintaining efficiency in sales and marketing, particularly through leveraging their customer database and email marketing program.
In the base case scenario, the analyst credits Beyond for several initiatives, including continued gross margin expansion, better leverage of fixed operating expenses, and more efficient sales and marketing.
Despite these positive factors, the analyst remains concerned about the company’s adjusted EBITDA performance.
Also Read: BYON shares are trading lower by 3.47% to $5.695 at last check Wednesday.
Photo by JHVEPhoto via Shutterstock.
Read Next:
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.